parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
| dc.contributor.author | Poorkaj, Parvoneh | en_US |
| dc.contributor.author | Moses, Lina | en_US |
| dc.contributor.author | Montimurro, Jennifer S. | en_US |
| dc.contributor.author | Nutt, John G. | en_US |
| dc.contributor.author | Schellenberg, Gerard D. | en_US |
| dc.contributor.author | Payami, Haydeh | en_US |
| dc.date.accessioned | 2010-05-06T20:03:28Z | |
| dc.date.available | 2010-05-06T20:03:28Z | |
| dc.date.issued | 2005 | en_US |
| dc.description.abstract | Background: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to lateonset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age at onset resembling anticipation. A subset of familial PD exhibits anticipation, the cause of which is unknown. The aim of this study was to determine if anticipation was due to parkin mutation dosage. Methods: We studied 19 kindreds that had early-onset parkinsonism in the offspring generation, late-onset parkinsonism in the parent generation, and = 20 years of anticipation. We also studied 28 early-onset parkinsonism cases without anticipation. Patients were diagnosed by neurologists at a movement disorder clinic. parkin analysis included sequencing and dosage analysis of all 12 exons. Results: Only one of 19 cases had compound parkin mutations, but contrary to our postulate, the affected relative with late-onset parkinsonism did not have a parkin mutation. In effect, none of the anticipation cases could be attributed to parkin. In contrast, 21% of early-onset parkinsonism patients without anticipation had parkin mutations. Conclusion: Anticipation is not linked to parkin, and may signify a distinct disease entity. | en_US |
| dc.description.sponsorship | Financial support was provided by grants from the National Institutes of Health (RO1 NS36960) and the Veterans' Administration (PADRECC). | en_US |
| dc.identifier.citation | Poorkaj P, Moses L, Montimurro J, et al. parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism. BMC Neurology. 2005;5(1):4. | en_US |
| dc.identifier.other | 10.1186/1471-2377-5-4 | en_US |
| dc.identifier.uri | http://www.biomedcentral.com/1471-2377/5/4 | en_US |
| dc.identifier.uri | http://hdl.handle.net/1773/15821 | |
| dc.language.iso | en_US | en_US |
| dc.title | parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
